The effects of ERBB2 and RAS overexpression on the metastatic potentials of LnCaP, DU145, PC3, and Myc-CaP prostate cancer cell lines were first assessed by performing a wound healing assay. This evidence concerns the gene ERBB2 and prostate cancer.